MedTrace Logo

Coronary Artery Disease in Patients Suffering From Schizophrenia

NCT02885792 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 300

Last updated 2017-01-31

No results posted yet for this study

Summary

Schizophrenia is a severe mental illness associated with excess mortality and affecting nearly 1% of the population. The average life expectancy for patients diagnosed with schizophrenia has been 55-60 years through the last generations in Denmark, while the general population has over the same period of time experienced an increase in life expectancy. As a result, the standardized mortality rate for patients with schizophrenia has increased markedly over the last three decades and is currently a major public health concern. Causes of death are mainly cardiovascular disease and patients diagnosed with schizophrenia has a relative risk of cardiovascular disease that is about 2-fold higher than the general population.

Conditions

Interventions

OTHER

Illness history

Existing psychiatric and somatic diagnosis and treatment. Charlson co-morbidity Index.

OTHER

Measure of social conditions

A self-report questionnaire measuring social isolation, including relations to family and friends.

OTHER

Measure of psychiatric condition

This method measures symptom severity, therapeutic response and general improvement, suicidal ideation, cognitive insight and awareness of illness and need for treatment and the ability to relabel symptoms.

PROCEDURE

Cardiovascular measurement

This procedure is used to detect early identification of cardiovascular disease progression.

Sponsors & Collaborators

  • Aalborg Psychiatric Hospital

    lead OTHER

Principal Investigators

  • Svend E. Jensen, MD · Aalborg University Hospital, Psychiatric Hospital

Study Design

Allocation
NON_RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-09-30
Primary Completion
2019-09-30
Completion
2020-09-30

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02885792 on ClinicalTrials.gov